<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-036343</identifier>
<setSpec>0210-5705</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Gastroesophageal reflux disease refractory to esomeprazole</dc:title>
<dc:description xml:lang="en">Resistance to proton pump inhibitors (PPI) in gastroesophage alreflux disease (GERD), which has been described in patients treated with omeprazole, could explain some exceptional cases of treatment failure and the need for surgery. The objective test of resistance to PPI is obtained with 24-hourintragastric pH-metry performed during treatment. A gastricpH of less than 4 for more than 50% of recording time indicates resistance. We present a patient with non-erosive GERD and treatment failure to omeprazole and proven resistance to esomeprazole which, to our knowledge, has only been reported in patients with Barrett&#146;s esophagus</dc:description>
<dc:creator>Velasco, M. J</dc:creator>
<dc:creator>Ortiz, V</dc:creator>
<dc:creator>Ponce, J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La resistencia al tratamiento con inhibidores de la bomba de protones (IBP) en la enfermedad por reflujo gastroesofágico(ERGE), descrita en pacientes tratados con omeprazol, puede explicar algunos casos excepcionales de fracaso terapéutico y la pertinencia de indicar tratamiento quirúrgico. La prueba objetiva de resistencia a IBP se obtiene con pHmetría intragástrica de 24 h, realizada en el curso del tratamiento, al encontrar un pH gástrico inferior a 4 más del50% del tiempo de registro. Se presenta un paciente con ERGE no erosiva con fracaso clínico al tratamiento con omeprazol y resistencia probada a es omeprazol que, en nuestro conocimiento, sólo se ha documentado en pacientes con esófago de Barrett</dc:description>
<dc:source>Gastroenterol Hepatol;28(2): 65-67, feb. 2005. graf</dc:source>
<dc:identifier>ibc-036343</dc:identifier>
<dc:title xml:lang="es">Enfermedad por reflujo gastroesofágico refractaria a esomeprazol</dc:title>
<dc:subject>^d7014</dc:subject>
<dc:subject>^d30587^s22006</dc:subject>
<dc:subject>^d19276^s22073</dc:subject>
<dc:subject>^d5886</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d24004^s22057</dc:subject>
<dc:subject>^d908^s22073</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d24004^s22016</dc:subject>
<dc:subject>^d30472</dc:subject>
<dc:type>article</dc:type>
<dc:date>200502</dc:date>
</metadata>
</record>
</ibecs-document>
